SHPH
Income statement / Annual
Last year (2024), Shuttle Pharmaceuticals Holdings, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Shuttle Pharmaceuticals Holdings, Inc.'s net income was -$9.14 B.
See Shuttle Pharmaceuticals Holdings, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$6.81 K
|
$66.83 K
|
$60.83 K
|
$54.95 K
|
$18.00 K
|
$18.74 K
|
| Gross Profit |
$0.00
|
-$6.81 K
|
-$66.83 K
|
-$60.83 K
|
-$54.95 K
|
-$18.00 K
|
-$18.74 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$3.62 B
|
$3.52 M
|
$1.49 M
|
$1.02 M
|
$161.77 K
|
$55.57 K
|
-$836.00
|
| General & Administrative Expenses |
$1.39 B
|
$1.05 M
|
$1.07 M
|
$721.18 K
|
$347.75 K
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.39 B
|
$1.05 M
|
$1.07 M
|
$721.18 K
|
$347.75 K
|
$513.06 K
|
$185.99 K
|
| Other Expenses |
$2.68 B
|
$1.33 M
|
$328.69 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$7.69 M
|
$5.89 M
|
$2.55 M
|
$1.74 M
|
$509.52 K
|
$568.63 K
|
$185.15 K
|
| Cost And Expenses |
$0.00
|
$5.89 M
|
$2.55 M
|
$1.74 M
|
$509.52 K
|
$586.63 K
|
$203.89 K
|
| Interest Income |
$38.14 M
|
$79.12 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$1.36 M
|
$2.60 M
|
$969.89 K
|
$50.79 K
|
$39.63 K
|
$30.92 K
|
$10.88 K
|
| Depreciation & Amortization |
$0.00
|
$6.81 K
|
$5.97 K
|
$60.83 K
|
$54.95 K
|
$18.00 K
|
$18.74 K
|
| EBITDA |
-$7.70 B |
-$3.99 M |
-$4.32 M |
-$1.04 M |
-$711.15 K |
-$577.22 K |
-$183.97 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$1.45 B
|
-$700.34 K
|
-$474.17 K
|
$590.86 K
|
-$296.21 K
|
-$39.51 K
|
-$9.70 K
|
| Income Before Tax |
-$9.14 B
|
-$6.59 M
|
-$3.03 M
|
-$1.15 M
|
-$805.73 K
|
-$626.14 K
|
-$213.59 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$71.01 K
|
$50.79 K
|
$39.63 K
|
$0.00
|
$0.00
|
| Net Income |
-$9.14 B
|
-$6.59 M
|
-$3.10 M
|
-$1.20 M
|
-$845.36 K
|
-$626.14 K
|
-$213.59 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-3186.21 |
-0.41 |
-0.3 |
-0.0885 |
-0.0622 |
-0.0461 |
-0.0157 |
| EPS Diluted |
-3167.28 |
-0.41 |
-0.3 |
-0.0885 |
-0.0622 |
-0.0461 |
-0.0157 |
| Weighted Average Shares Out |
$2.87 M
|
$15.91 M
|
$10.35 M
|
$13.59 M
|
$13.59 M
|
$13.59 M
|
$13.59 M
|
| Weighted Average Shares Out Diluted |
$2.89 M
|
$15.91 M
|
$10.35 M
|
$13.59 M
|
$13.59 M
|
$13.59 M
|
$13.59 M
|
| Link |
|
|
|
|
|
|
|
